Scinovex
review Open Access

Upstream and downstream of mTOR

Genes & Development · 2004 · Vol. 18(16) · pp. 1926–1945
Nissim HayNahum Sonenberg

Abstract

The evolutionarily conserved checkpoint protein kinase, TOR (target of rapamycin), has emerged as a major effector of cell growth and proliferation via the regulation of protein synthesis. Work in the last decade clearly demonstrates that TOR controls protein synthesis through a stunning number of downstream targets. Some of the targets are phosphorylated directly by TOR, but many are phosphorylated indirectly. In this review, we summarize some recent developments in this fast-evolving field. We describe both the upstream components of the signaling pathway(s) that activates mammalian TOR (mTOR) and the downstream targets that affect protein synthesis. We also summarize the roles of mTOR in the control of cell growth and proliferation, as well as its relevance to cancer and synaptic plasticity.

PI3K/AKT/mTOR signaling in cancerCRISPR and Genetic EngineeringGenomics, phytochemicals, and oxidative stressBiologyPI3K/AKT/mTOR pathwayEffectorCell biologyTOR signalingUpstream and downstream (DNA)PhosphorylationDownstream (manufacturing)Cell growthSignal transduction

MeSH terms

AnimalsCell DivisionEnergy MetabolismGrowth SubstancesNeoplasmsPeptide Initiation FactorsPhosphorylationProtein KinasesTranscription, GeneticProtein BiosynthesisRibosomal Protein S6 KinasesTOR Serine-Threonine Kinases

Funding

  • Howard Hughes Medical Institute
  • National Institutes of Health
  • Canadian Institutes of Health Research
Citations
4,184
FWCI
field-weighted impact
References
222
Percentile
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.